Determination of sulfates of androsterone and epiandrosterone in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry.

A promising liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) for analysis of the sulfates of 5alpha-androgen, androsterone and epiandrosterone (A-S and EpiA-S) in human serum was developed. The method was used to assess one of the markers of 5alpha-reductase activity of males including patients with prostate cancer (PC). After deproteinization with acetonitrile, the androgen sulfates and the internal standard, [7,7,16,16-2H4]dehydroepiandrosterone-S, were extracted from human serum using a solid-phase extraction cartridge and washed with hexane. The extract was reconstituted and applied to the LC/ESI-MS system operated in the selected ion monitoring mode. The method was validated over the range 0.02-5 microg/mL (A-S) and 0.005-1.5 microg/mL (EpiA-S) using 10 microL of human serum. The method was a concise procedure without chemical or enzymatic hydrolysis of the conjugates, purification by high-performance liquid chromatography and/or derivatization, and proved to be satisfactory in its reproducibility and accuracy. The levels of these androgen sulfates tended to decrease during aging, and the A-S levels in the sera obtained from both healthy males and patients with PC were correlated with their EpiA-S levels.

[1]  A. Terracciano,et al.  Development of a liquid chromatography–tandem mass spectrometry method for the identification of natural androgen steroids and their conjugates in urine samples , 2004 .

[2]  H. Fujita,et al.  The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor , 2004, Cancer Research.

[3]  A. Mizokami,et al.  Simultaneous determination of androstenediol 3-sulfate and dehydroepiandrosterone sulfate in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  A. Mizokami,et al.  Identification of dehydroepiandrosterone metabolites formed from human prostate homogenate using liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. , 2002, Journal of chromatography. A.

[5]  K. Hara,et al.  Identification of human urine stains by HPLC analysis of 17-ketosteroid conjugates. , 2002, Journal of forensic sciences.

[6]  W. Steers 5α-reductase activity in the prostate , 2001 .

[7]  T. Higashi,et al.  Gas chromatography and high-performance liquid chromatography of natural steroids. , 2001, Journal of chromatography. A.

[8]  S. Orndorff,et al.  Quantification of urine 17-ketosteroid sulfates and glucuronides by high-performance liquid chromatography-ion trap mass spectroscopy. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[9]  S. Yeh,et al.  Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Messing,et al.  Δ5-Androstenediol is a natural hormone with androgenic activity in human prostate cancer cells , 1998 .

[11]  John G Lewis,et al.  Plasma androsterone/epiandrosterone sulfates as markers of 5α-reductase activity: Effect of finasteride in normal men , 1997, Steroids.

[12]  J. Goméz,et al.  Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. , 1997, The Journal of clinical endocrinology and metabolism.

[13]  J. Goméz,et al.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. , 1994, The Journal of clinical endocrinology and metabolism.

[14]  C. Kletke,et al.  Dehydroepiandrosterone sulfate quantification in serum using high-performance liquid chromatography/ mass spectrometry and a deuterated internal standard: a technique suitable for routine use or as a reference method , 1990, Steroids.

[15]  F. Labrie,et al.  Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer. , 1986, Journal of steroid biochemistry.

[16]  D. B. Gower Extraction, purification and estimation of the androgens and their derivatives , 1995 .

[17]  J. Isaacs Role of androgens in prostatic cancer. , 1994, Vitamins and hormones.

[18]  R. Rittmaster,et al.  Androsterone sulfate: physiology and clinical significance in hirsute women. , 1993, The Journal of clinical endocrinology and metabolism.